(firstQuint)TAK-875 Glimepiride Drug-Interaction Study.

 TAK-875 is being developed at Takeda Global Research and Development, Inc.

 as an adjunct to diet and exercise to improve glycemic control in participants with T2DM.

 This study will determine whether administration of glimepiride alters the pharmacokinetics (PK) of TAK-875, and whether TAK-875 affects the PK of glimepiride.

.

 TAK-875 Glimepiride Drug-Interaction Study@highlight

The purpose of this study is to determine the pharmacokinetics and safety of TAK-875, once daily (QD), with and without glimepiride in participants with type 2 diabetes mellitus (T2DM).

